StockSelector.com
  Research, Select, & Monitor Friday, April 03, 2020 3:25:58 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Amneal Pharmaceuticals, Inc.$3.05$.02.66%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Amneal Pharmaceuticals, Inc. has an overall rank of 3427 out of 7217 stocks based on 10 positive rankings and 8 negative rankings.

Positive Rankings
Estimated EPS Growth
Amneal Pharmaceuticals rank is 138
Up EPS Surprise
Amneal Pharmaceuticals beat the consensus earnings estimate when it last reported quarterly earnings.
Top Intrinsic Values
Amneal Pharmaceuticals rank is 221
PEGValue
Amneal Pharmaceuticals has a PEG Value of $7.80. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 155.85% in the next year. Among companies with a PEG Value above the current stock price, Amneal Pharmaceuticals is ranked 328.
Historic Revenue Growth
Amneal Pharmaceuticals rank is 525
90 Day Gain
Amneal Pharmaceuticals rank is 583
Low vPut/Call
Amneal Pharmaceuticals has a low Put/Call ratio of 0.32 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Amneal Pharmaceuticals is ranked 603.
Low Put/Call
Amneal Pharmaceuticals has a low Put/Call ratio of 0.27 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Amneal Pharmaceuticals is ranked 733.
SSValue
The StockSelector Value for Amneal Pharmaceuticals is $6.65. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Amneal Pharmaceuticals is ranked 796.
Price-to-Sales
Amneal Pharmaceuticals rank is 1361
Negative Rankings
Debt-to-Equity
Amneal Pharmaceuticals rank is 250
Negative ROE
Amneal Pharmaceuticals rank is 271
Negative Cash Growth
Amneal Pharmaceuticals rank is 287
Negative Past Growth
Amneal Pharmaceuticals rank is 370
Negative Net Margin
Amneal Pharmaceuticals rank is 743
Negative ROA
Amneal Pharmaceuticals rank is 952
10 Day Loss
Amneal Pharmaceuticals rank is 1194
Price-to-Book
Amneal Pharmaceuticals rank is 1197







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.